ARVN - Arvinas draws Buy at Goldman Sachs on breast cancer therapy
2024-02-01 15:42:17 ET
More on Arvinas
- Arvinas: Positive Breast Cancer Data Leads To Other Developments
- Arvinas: Protein Degradation Pioneer Presents An Intriguing Speculative Buy Opportunity
- Wells Fargo upgrades Arvinas to overweight ahead of Phase 3 data readout
- Jefferies upgrades Arvinas to buy in wake of positive ARV-471 data
- Seeking Alpha’s Quant Rating on Arvinas